Eur J Nucl Med Mol Imaging: Myocardial perfusion imaging can predict the prognosis of asymptomatic diabetic patients with high cardiovascular risk

Basel asymptomatic high-risk diabetes test results (BARDOT) patients show that the 2-year follow-up, asymptomatic patients with diabetes have abnormal myocardial perfusion scintigraphy (MPS) of major adverse medsci.

Diabetes, medsci.

In short-term follow-up, the relatively low incidence of MACEs may be the main reason for the controversial benefits of noninvasive evaluation of CAD in screening asymptomatic diabetic patients.

In the BARDOT multicenter trial, 400 asymptomatic diabetic patients with high cardiovascular risk were enrolled for myocardial perfusion SPECT (MPS) .

In the BARDOT multicenter trial, 400 asymptomatic diabetic patients with high cardiovascular risk were enrolled for myocardial perfusion SPECT (MPS) .

The annual mortality rate of patients with normal and abnormal MPS, the total mortality rate every 5 years, and the average annual mortality rate.

The annual mortality rate of patients with normal and abnormal MPS, the total mortality rate every 5 years, and the average annual mortality rate.

In summary, during the 5- year follow-up period, MPS may have prognostic value for asymptomatic diabetic patients with high cardiovascular risk.

In the 5 5 follow-up period of years, in the follow-up period, MPS MPS may have prognostic value in asymptomatic diabetic patients with high cardiovascular risk.

org/10.

org/10.
1007/s00259-021-05349-5" target="_blank" rel="noopener">Caobelli, F.
, Haaf, P.
, Haenny, G.
et al.
 Prognostic value of myocardial perfusion scintigraphy in asymptomatic patients with diabetes mellitus at high cardiovascular risk: 5-year follow-up of the prospective multicenter BARDOT trial.
  Eur J Nucl MoI Imaging med  (2021).
https://doi.
org/10.
1007/s00259-021-05349-5 Caobelli, F.
, Haaf, P.
, Haenny, G.
  et Al.
Eur J Nucl Med MoI Imaging in this message